Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Finasteride treats hair loss but may affect prostate cancer detection.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.

Vertex pattern hair loss linked to higher prostate cancer risk.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Dutasteride may help shrink prostate cancer tumors.

Physical activity, height, and smoking affect prostate cancer risk.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Certain natural compounds called terpenes may help prevent prostate cancer.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Obesity is linked to more severe lower urinary tract symptoms.